IPHYF
Price
$2.06
Change
+$0.75 (+57.25%)
Updated
Aug 11 closing price
Capitalization
208.55M
KNBIF
Price
$0.03
Change
-$0.00 (-0.00%)
Updated
Aug 11 closing price
Capitalization
5.42M
Interact to see
Advertisement

IPHYF vs KNBIF

Header iconIPHYF vs KNBIF Comparison
Open Charts IPHYF vs KNBIFBanner chart's image
Innate Pharma
Price$2.06
Change+$0.75 (+57.25%)
Volume$300
Capitalization208.55M
Kane Biotech
Price$0.03
Change-$0.00 (-0.00%)
Volume$100
Capitalization5.42M
IPHYF vs KNBIF Comparison Chart in %
Loading...
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IPHYF vs. KNBIF commentary
Aug 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IPHYF is a Buy and KNBIF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 16, 2025
Stock price -- (IPHYF: $2.06 vs. KNBIF: $0.03)
Brand notoriety: IPHYF and KNBIF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IPHYF: 57% vs. KNBIF: 1%
Market capitalization -- IPHYF: $208.55M vs. KNBIF: $5.42M
IPHYF [@Biotechnology] is valued at $208.55M. KNBIF’s [@Biotechnology] market capitalization is $5.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IPHYF’s FA Score shows that 0 FA rating(s) are green whileKNBIF’s FA Score has 1 green FA rating(s).

  • IPHYF’s FA Score: 0 green, 5 red.
  • KNBIF’s FA Score: 1 green, 4 red.
According to our system of comparison, both IPHYF and KNBIF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IPHYF’s TA Score shows that 4 TA indicator(s) are bullish while KNBIF’s TA Score has 5 bullish TA indicator(s).

  • IPHYF’s TA Score: 4 bullish, 3 bearish.
  • KNBIF’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KNBIF is a better buy in the short-term than IPHYF.

Price Growth

IPHYF (@Biotechnology) experienced а +57.21% price change this week, while KNBIF (@Biotechnology) price change was -3.28% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.90%. For the same industry, the average monthly price growth was +26.70%, and the average quarterly price growth was +20.91%.

Industries' Descriptions

@Biotechnology (+9.90% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IPHYF($209M) has a higher market cap than KNBIF($5.42M). IPHYF YTD gains are higher at: -28.983 vs. KNBIF (-61.688).
IPHYFKNBIFIPHYF / KNBIF
Capitalization209M5.42M3,853%
EBITDAN/A-3.7M-
Gain YTD-28.983-61.68847%
P/E RatioN/A1.07-
RevenueN/A2.44M-
Total CashN/A494K-
Total DebtN/A2.08M-
FUNDAMENTALS RATINGS
IPHYF vs KNBIF: Fundamental Ratings
IPHYF
KNBIF
OUTLOOK RATING
1..100
4186
VALUATION
overvalued / fair valued / undervalued
1..100
75
Overvalued
30
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
94100
PRICE GROWTH RATING
1..100
3993
P/E GROWTH RATING
1..100
10093
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

KNBIF's Valuation (30) in the null industry is somewhat better than the same rating for IPHYF (75). This means that KNBIF’s stock grew somewhat faster than IPHYF’s over the last 12 months.

KNBIF's Profit vs Risk Rating (100) in the null industry is in the same range as IPHYF (100). This means that KNBIF’s stock grew similarly to IPHYF’s over the last 12 months.

IPHYF's SMR Rating (94) in the null industry is in the same range as KNBIF (100). This means that IPHYF’s stock grew similarly to KNBIF’s over the last 12 months.

IPHYF's Price Growth Rating (39) in the null industry is somewhat better than the same rating for KNBIF (93). This means that IPHYF’s stock grew somewhat faster than KNBIF’s over the last 12 months.

KNBIF's P/E Growth Rating (93) in the null industry is in the same range as IPHYF (100). This means that KNBIF’s stock grew similarly to IPHYF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IPHYFKNBIF
RSI
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
62%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
71%
Momentum
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
66%
MACD
ODDS (%)
Bullish Trend 1 day ago
50%
Bullish Trend 1 day ago
64%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
45%
Bearish Trend 1 day ago
64%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
40%
Bearish Trend 1 day ago
63%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
54%
Declines
ODDS (%)
N/A
Bearish Trend 30 days ago
56%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
70%
Aroon
ODDS (%)
Bearish Trend 1 day ago
56%
Bearish Trend 1 day ago
58%
View a ticker or compare two or three
Interact to see
Advertisement
IPHYF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KNBIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HURA3.060.30
+10.87%
TuHURA Biosciences Inc
SSRM16.780.70
+4.35%
SSR Mining
TXMD1.170.02
+1.71%
TherapeuticsMD
SENEB104.50N/A
N/A
Seneca Foods Corp
ROL57.33-0.09
-0.16%
Rollins

IPHYF and

Correlation & Price change

A.I.dvisor tells us that IPHYF and KNBIF have been poorly correlated (+6% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IPHYF and KNBIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPHYF
1D Price
Change %
IPHYF100%
N/A
KNBIF - IPHYF
6%
Poorly correlated
N/A
INNMF - IPHYF
6%
Poorly correlated
N/A
OTLC - IPHYF
4%
Poorly correlated
+1.64%
ISCO - IPHYF
1%
Poorly correlated
N/A
LIXT - IPHYF
1%
Poorly correlated
-7.95%
More

KNBIF and

Correlation & Price change

A.I.dvisor tells us that KNBIF and CADL have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that KNBIF and CADL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNBIF
1D Price
Change %
KNBIF100%
N/A
CADL - KNBIF
22%
Poorly correlated
+0.83%
LQDA - KNBIF
21%
Poorly correlated
-0.54%
SPHDF - KNBIF
20%
Poorly correlated
N/A
MMIRF - KNBIF
12%
Poorly correlated
N/A
IPHYF - KNBIF
6%
Poorly correlated
N/A
More